Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07261644 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS)

Name: A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS) — clinical trial record (NCT07261644)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 3

SponsorSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Started2025-11-07

View on ClinicalTrials.gov ↗

Amendment history

2025-12-03

Study Identification, Study Status v1

Study title+25 characters

~~Phase III~~A Study to Evaluate the Efficacy and Safety of 608 in ~~the~~Adult ~~Treatment~~Subjects ofWith Active Ankylosing Spondylitis ~~in Adults~~(AS)

2025-11-21

Original filing

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

22 trials monitored

See all monitored trials

Ankylosing Spondylitis

176 trials monitored

See 6 trials at risk

This study will evaluate the efficacy and safety of 608 in patients with AS.

Trial Details

NCT Number	NCT07261644
Lead Sponsor	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions	Ankylosing Spondylitis
Enrollment	500 participants
Start Date	2025-11-07
Primary Completion	2027-01-14 (estimated)
Study Completion	2027-11-18 (estimated)
Updated on ClinicalTrials.gov	2025-12-10